05/02/2024 1:39 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 1:03 PM | Arrowhead Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/03/2024 5:05 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:30 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 6:06 PM | Arrowhead Pharmaceuticals (Issuer) Lu Hongbo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 3:38 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 6:00 PM | Arrowhead Pharmaceuticals (Issuer) Lu Hongbo (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
|
03/08/2024 4:54 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:30 PM | Arrowhead Pharmaceuticals (Subject) Myszkowski Kenneth Allen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:25 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:57 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024 4:28 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEFA14A | |
01/24/2024 11:57 AM | Arrowhead Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024 3:14 PM | Arrowhead Pharmaceuticals (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/17/2024 5:32 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:22 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144/A | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Ferrari Mauro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:48 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 3:38 PM | Arrowhead Pharmaceuticals (Subject) Arrowhead Pharmaceuticals (Subject) Waddill William D. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 3:22 PM | Arrowhead Pharmaceuticals (Subject) Ferrari Mauro (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 4:16 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:16 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:17 PM | Arrowhead Pharmaceuticals (Issuer) Oliver Tracie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 6:58 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 7:02 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 4:33 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 4:14 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:39 PM | Arrowhead Pharmaceuticals (Subject) Myszkowski Kenneth Allen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:21 PM | Arrowhead Pharmaceuticals (Subject) San Martin Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:08 PM | Arrowhead Pharmaceuticals (Subject) Oliver Tracie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 4:25 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:27 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 12:49 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 12:06 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 12:25 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 11:24 AM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:44 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 4:04 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The asset beating inflation by 4x (Ad) "Trump Loophole" Beats Inflation?
Inflation has been out of control for years.
Forcing you to work longer and harder for more money that is worth less.
By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties. That's why we have released our Free Precious Metals Investment Guide that explains all the details |
12/21/2023 3:34 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023 2:51 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:52 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:54 PM | Arrowhead Pharmaceuticals (Issuer) OLUKOTUN ADEOYE Y (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:55 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:41 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:16 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 3:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 1:31 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/27/2023 5:23 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:51 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 1:50 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 5:10 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:20 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/06/2023 5:04 PM | Arrowhead Pharmaceuticals (Issuer) Oliver Tracie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2023 5:15 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 12:04 PM | Arrowhead Pharmaceuticals (Subject) Oliver Tracie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023 12:33 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023 5:41 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 1:15 PM | Arrowhead Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
05/08/2023 5:29 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 6:04 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 1:36 PM | Arrowhead Pharmaceuticals (Subject) GIVEN DOUGLAS B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |